China Shanghai International Pharmaceutical Raw Materials Exhibition

The China International API Exhibition (API China), the longest-running trade show in China’s pharmaceutical sector, was first launched in 1968. Its exhibits encompass not only more than 50,000 APIs across 24 major categories but also all excipients, functional ingredients, primary and secondary packaging materials, as well as production and testing equipment required for the manufacture of pharmaceuticals and health products.

With the ongoing implementation of generic drug consistency evaluations and the introduction of a joint review-and-approval policy for APIs, excipients, and packaging materials, pharmaceutical companies are increasingly taking responsibility for product quality, thereby significantly boosting the proactive engagement of API manufacturers.

The China International API Exhibition (API China)has become an efficient, one-stop industry platform for tens of thousands of domestic and international pharmaceutical and health‑product manufacturers, offering an unparalleled opportunity to gain a comprehensive understanding of emerging trends in China’s pharmaceutical and health‑product sectors, forge valuable industry connections, and uncover new business prospects. (Copyright of this content belongs to Juzhan; unauthorized reproduction is prohibited.)

The China International API Exhibition (API China)is poised to unleash fresh momentum as the joint review-and-approval system takes effect. Leading Chinese pharmaceutical giants—including Sinopharm Group, Tianjin Pharmaceutical Group, Shanghai Pharmaceuticals Holding Co., Ltd., Qilu Pharmaceutical, Northeast Pharmaceutical Group, Shandong Xinhua Pharmaceutical, Lizhu Group, Huahai Pharmaceutical, Haizheng Pharmaceutical, Chuanuo Pharmaceutical, Hengxin Pharmaceutical, Disheng Pharmaceutical, and Erkang Pharmaceutical—will gather to showcase their time‑tested flagship products alongside cutting‑edge innovations developed through the latest R&D efforts.

China Shanghai International Pharmaceutical Raw Materials Exhibition tickets are e-tickets. Mainland China visitors must complete online pre-registration with real-name ID verification; overseas visitors must use passport verification; Hong Kong, Macao, and Taiwan visitors must use their travel permit. On site, verify entry with your ID card or by scanning the e-ticket QR code.

Partial exhibitor directory and exhibitor list for China Shanghai International Pharmaceutical Raw Materials Exhibition: 安徽安特食品股份有限公司, 瑞阳制药股份有限公司, 保定思诺流体科技有限公司, 江苏科伦多食品配料有限公司, 安徽亚兰密封件股份有限公司, and others. The 2026 edition is expected to feature 500+ exhibiting companies. To obtain the full exhibitor directory (including booth numbers and contact details), please visit the official exhibition website or contact Jufair.

The Exhibition Value of API China

• API China is the longest-running and largest specialized trade show in China’s pharmaceutical industry. Since its inception in 1968, it has been successfully held for more than ninety editions and is widely recognized by the industry as a leading indicator of trends in China’s pharmaceutical sector and a central hub of the global pharmaceutical raw-materials supply chain. Co-organized by the China Chamber of Commerce for Import & Export of Medicines & Health Products and Reed Sinopharm, the event has cultivated deep roots in the industry for nearly six decades. It stands as an indispensable annual gathering for the entire pharmaceutical R&D and manufacturing value chain, often hailed as the “barometer” of China’s pharmaceutical industry.
• The core value of participating lies in its unparalleled ability to cover the entire industry chain and its unique platform that precisely connects with key buyers in China’s pharmaceutical sector. The exhibition showcases dozens of major product categories—ranging from pharmaceutical APIs and excipients to pharmaceutical packaging, manufacturing equipment, natural products, and biopharmaceutical supply-chain solutions—encompassing tens of thousands of items. From R&D through production, packaging, and distribution, it forms a complete industrial ecosystem. Each edition attracts nearly 5,000 pharmaceutical companies from across the country, with 97% of China’s top 100 pharmaceutical enterprises sending delegation-level participation. For API and excipient manufacturers, it is the preferred platform for entering China’s pharmaceutical supply chain and expanding into the domestic market.
• The exhibition aligns closely with three major industry trends—integrated API–formulation development, green manufacturing, and internationalization—thereby establishing a cutting-edge technological hub characterized by deep integration among industry, academia, research, and application. Driven by policies promoting centralized volume-based procurement, integrated API–formulation development has become the mainstream trend. Through the release of authoritative industry reports and policy‑interpretation forums, the exhibition provides robust support to help companies define their strategic direction. Concurrently, more than fifty high‑profile industry forums are held, addressing hot topics such as innovative drug R&D, technological upgrades, policy analysis, and overseas market expansion, with nearly one hundred renowned industry experts sharing their insights.
• For Chinese enterprises, this exhibition serves as a strategic gateway for tapping the domestic market, connecting with global resources, and showcasing their innovative capabilities. As a vital platform for international brands seeking to enter the Chinese market, globally recognized companies such as Rousselot, Capsugel, Sanofi, Merck, and Evonik have leveraged API China to establish relationships with Chinese customers and rapidly expand their operations in China. At the same time, the exhibition seamlessly integrates online and offline services, offering year-round, precision‑matched business‑opportunity matchmaking to help companies transcend geographical and temporal constraints and reach global audiences. Participating enterprises can use this platform to connect with China’s core procurement networks, seizing early opportunities in the high‑quality development of the pharmaceutical industry.

Notable exhibitors

• Pharmaceutical APIs and Intermediates:Sinopharm Group, Tianjin Pharmaceutical Group, Shanghai Pharmaceuticals Group, Qilu Pharmaceutical, Northeast Pharmaceutical, Shandong Xinhua, Lizhu Group, Huahai Pharmaceutical, Haizheng Pharmaceutical, Chuangnuo Pharmaceutical, Hengxin Pharmaceutical, Dishida Pharmaceutical, Erkang Pharmaceutical
• Internationally Renowned Brands:Roquette, Capsugel, Sanofi, Sartorius, Merck, Cytiva, SCHOTT, NEG, Corning, Kyowa Hakko, Fuji, Ajinomoto, Evonik, DSM, Pall Life Sciences
• Pharmaceutical Excipients:Jiangxi Alpha High-Tech Pharmaceutical, Chongqing Hengsheng Pharmaceutical Capsules, Tianrun Pharmaceutical, Erkang Pharmaceutical
• Pharmaceutical Packaging:Xi’an Debao Pharmaceutical Packaging, Xi’an Global Printing, Hebei Jingsong Plastics, Sichuan Tongguo Pharmaceutical Packaging, Zhejiang Wensheng Packaging, Tianjin Folhaowei Pharmaceutical Packaging, Nantong Huidécheng Packaging, Zhejiang Zhenhua Plastics, Suzhou Keshida Printing, Shanghai Jiatai Pharmaceutical Packaging, Guangdong Shitong Pharmaceutical Packaging, Shanghai Haishun New-Type Pharmaceutical Packaging, Apta (China) Investment, Shenzhen Baitefu Materials, Guangdong Meijieshi Holdings, Foshan Nanhai Xinbaode Plastics, Foshan Shunde District Shunfeng Pharmaceutical Packaging, Guilin Aoqun Color Printing, Zhejiang Gongdong Medical Devices, Chongqing Xinjitaï Pharmaceutical Spray Pumps, Jinshi Packaging (Jiaxing), Xuzhou Longrun Pharmaceutical Packaging, Zhejiang Shuokang Packaging, Harbin Pengcheng New Materials, Cang County Yongxin Pharmaceutical Packaging, Botou City Renhe Plastics, Hubei Limei Pharmaceutical Packaging, Nanjing Tianhua Technology, Shenzhen Tianlixing Technology, Zhongshan Huifeng Medical Packaging, Jiangxi Chunguang New Materials, Dongfeng Pharmaceutical Packaging, Shenzhen Jiuxing Printing & Packaging
• Pharmaceutical Equipment:Sinopharm Engineering, Koneng Power Technology, Oushisheng, Tianrun Pharmaceutical, Dongfulong, Chutian Technology, Xinhua Medical
• Biopharmaceuticals and R&D Services:Oushisheng (Flow Chemistry Systems), China National Pharmaceutical Group United Engineering